EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Roles of RNF168 in Tumor Progression

Tianyuan Xie, Hai Qin, Zhengdong Yuan, Yiwen Zhang, Xiaoman Li, Lufeng Zheng iD

Molecules · 2023

DOI: 10.3390/molecules28031417 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Tianyuan Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University, 639 Longmian Road,…. Hauptthemen laut MEDLINE: DNA Repair, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RING finger protein 168 (RNF168) is an E3 ubiquitin ligase with the RING finger domain. It is an important protein contributing to the DNA double-strand damage repair pathway. Recent studies have found that RNF168 is significantly implicated in the occurrence and development of various cancers. Additionally, RNF168 contributes to the drug resistance of tumor cells by enhancing their DNA repair ability or regulating the degradation of target proteins. This paper summarizes and prospects the research progress of the structure and main functions of RNF168, especially its roles and the underlying mechanisms in tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA RepairUbiquitin-Protein LigasesHumansCarcinogenesisUbiquitinationDNA Damage

Stichwörter der Autor:innen

DNA damage repairE3 ubiquitin ligaseRING finger protein familyRNF168cancer

Substanzen

Ubiquitin-Protein LigasesRNF168 protein, human

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University, 639 Longmian Road, Nanjing 211198, China.
  • Department of Clinical Laboratory, Guizhou Provincial Orthopedic Hospital, No. 206, Sixian Street, Baiyun District, Guiyang 550007, China.
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.

ORCID-Profile: Lufeng Zheng

Förderung

  • National Natural Science Foundation of China
  • Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions

Zitieren

APA

Xie, T., Qin, H., Yuan, Z., Zhang, Y., Li, X., & Zheng, L. (2023). Emerging Roles of RNF168 in Tumor Progression. Molecules. https://doi.org/10.3390/molecules28031417

Vancouver

Xie T, Qin H, Yuan Z, Zhang Y, Li X, Zheng L. Emerging Roles of RNF168 in Tumor Progression. Molecules. 2023. doi:10.3390/molecules28031417

BibTeX
@article{Xie2023,
  author = {Xie, Tianyuan and Qin, Hai and Yuan, Zhengdong and Zhang, Yiwen and Li, Xiaoman and Zheng, Lufeng},
  title = {Emerging Roles of RNF168 in Tumor Progression},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28031417}
}
Kostenlos starten →